J.B. Vermorken - Ovarian cancer - State of the art
Sipuleucel T Presentation Anna Begelfer Ostrovski
Angiogenic blockade and Tomotherapy in hepatocellular carcinoma
Regional Therapy for Metastatic Neuroendocrine Carcinoma
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) in Non-Small Cell Lung Cancer (NSCLC) Victor.
Novel Agents for Indolent Lymphoma and Mantle Cell Lymphoma Stephen Ansell, MD, PhD Mayo Clinic.
Novel Agents for Indolent L ymphoma and Mantle Cell Lymphoma
NOVEL THERAPIES: Frontline Approaches 2004 Brian G.M. Durie, M.D.
Werner Scheithauer Professor of Internal Medicine, Cancer Center at the Vienna University Hospital, Austria.
LUNG CANCER MOLECULAR THERAPY Prof. Dr. Can ÖZTÜRK
Jordi Bruix Head, BCLC Group, Liver Unit Hospital Clínic, University of Barcelona New drugs for Hepatocellular Carcinoma.
April 2012, Vol 3, No 2
